Missed GME or NVDA? Don’t Miss the Next One.​
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
Home › Stocks › Nutrien Ltd. (NTR) Stock Forecast & Price Prediction Canada | NYSE | Basic Materials | Agricultural Inputs
$58.89
-0.79 (-1.32%)10 Quality Stocks Worth Considering Now
Researching Nutrien (NTR) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on NTR and similar high-potential opportunities.
Based on our analysis of 35 Wall Street analysts, NTR has a bullish consensus with a median price target of $63.00 (ranging from $53.00 to $70.00). The overall analyst rating is Buy (7.8/10). Currently trading at $58.89, the median forecast implies a 7.0% upside. This outlook is supported by 16 Buy, 8 Hold, and 2 Sell ratings.
The most optimistic forecast comes from Andrew Wong at RBC Capital, projecting a 18.9% upside. Conversely, the most conservative target is provided by Duffy Fischer at Goldman Sachs, suggesting a 10.0% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for NTR.
Date | Firm | Analyst | Rating | Change | Price Target |
---|---|---|---|---|---|
May 14, 2025 | Scotiabank | Ben Isaacson | Sector Perform | Downgrade | $62.00 |
May 14, 2025 | Barclays | Benjamin Theurer | Equal-Weight | Maintains | $61.00 |
May 14, 2025 | B of A Securities | Steve Byrne | Buy | Maintains | $63.00 |
May 13, 2025 | Oppenheimer | Kristen Owen | Outperform | Maintains | $63.00 |
May 12, 2025 | RBC Capital | Andrew Wong | Outperform | Maintains | $65.00 |
May 12, 2025 | Wells Fargo | Richard Garchitorena | Equal-Weight | Maintains | $59.00 |
May 9, 2025 | Goldman Sachs | Duffy Fischer | Sell | Maintains | $59.00 |
May 8, 2025 | UBS | Eric Beaumont | Neutral | Maintains | $56.00 |
Apr 22, 2025 | Oppenheimer | Kristen Owen | Outperform | Maintains | $58.00 |
Apr 16, 2025 | UBS | Eric Beaumont | Neutral | Maintains | $52.00 |
Mar 13, 2025 | Goldman Sachs | Duffy Fischer | Sell | Initiates | $53.00 |
Mar 5, 2025 | Barclays | Benjamin Theurer | Equal-Weight | Maintains | $59.00 |
Feb 25, 2025 | CIBC | Outperformer | Maintains | $66.00 | |
Feb 24, 2025 | Scotiabank | Ben Isaacson | Sector Outperform | Maintains | $62.00 |
Feb 24, 2025 | RBC Capital | Andrew Wong | Outperform | Reiterates | $60.00 |
Feb 21, 2025 | Wells Fargo | Richard Garchitorena | Equal-Weight | Maintains | $56.00 |
Feb 20, 2025 | Mizuho | Christopher Parkinson | Neutral | Maintains | $55.00 |
Feb 20, 2025 | UBS | Eric Beaumont | Neutral | Maintains | $54.00 |
Feb 10, 2025 | Scotiabank | Ben Isaacson | Sector Outperform | Maintains | $60.00 |
Jan 28, 2025 | UBS | Joshua Spector | Neutral | Maintains | $53.00 |
The following stocks are similar to Nutrien based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Nutrien Ltd. has a market capitalization of $28.69B with a P/E ratio of 55.5x. The company generates $24.74B in trailing twelve-month revenue with a 2.1% profit margin.
Revenue growth is -5.4% quarter-over-quarter, while maintaining an operating margin of +4.7% and return on equity of +2.3%.
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Provider of crop inputs and services.
The company generates revenue by producing and selling essential fertilizers like potash and nitrogen, alongside offering agricultural solutions and technology-driven services through its Retail segment. Nutrien operates a vast distribution network with over 1,500 retail locations, allowing it to effectively reach farmers and agricultural businesses globally.
Headquartered in Saskatoon, Canada, Nutrien is recognized for its significant role in the agriculture industry, enhancing food production and supporting sustainable practices. The company's various segments position it to address the global demand for efficient farming solutions and impact food supply chains.
Basic Materials
Agricultural Inputs
25,500
Mr. Kenneth A. Seitz
Canada
2007
Nutrien Ltd. will participate in the BMO 2025 Farm to Market Conference on May 15, 2025, at 11:00 AM ET, with Mark Thompson as a key speaker.
Nutrien's participation in a major conference signals its strategic focus and potential growth opportunities, which could influence stock performance and investor sentiment.
NTR reported a decline in Q1 net earnings and adjusted EBITDA, attributed to lower potash prices in North America, increased phosphate expenses, and decreased retail earnings.
NTR's declining earnings and EBITDA signal potential profitability issues, impacting investor sentiment and stock performance amid decreasing potash prices and rising costs.
Nutrien's Q1 2025 results indicate sustained margin pressure from lower selling prices and cost challenges, suggesting investors should adjust near-term expectations. Recent share price gains may be premature.
Nutrien's lower Q1 results and ongoing margin pressures suggest a potential decline in profitability, indicating that recent share price gains may lack sustainability.
Nutrien Ltd. (NYSE:NTR) will hold its Q1 2025 earnings conference call on May 8, 2025, at 10:00 AM ET, featuring key executives and analysts from major financial institutions.
The earnings call provides insights into Nutrien's financial health and strategic direction, influencing stock performance and investor sentiment in the agricultural sector.
Nutrien Ltd. (TSX: NTR, NYSE: NTR) CFO Mark Thompson will speak at the BMO Farm to Market Conference on May 15 at 11:00 am EDT, with a live video available on their website.
Mark Thompson's appearance at the BMO Farm to Market Conference could provide insights into Nutrien's financial health and growth strategy, influencing investor sentiment and stock performance.
Nutrien Ltd.'s Q1 2025 results fell short of estimates, with a 40% drop in retail EBITDA. Despite segment declines, management upheld full-year guidance and emphasized cost savings and share repurchases.
Nutrien's Q1 miss highlights short-term challenges but maintained full-year guidance suggests potential recovery. Cost savings and share repurchase indicate management's confidence in long-term growth.
Based on our analysis of 35 Wall Street analysts, Nutrien Ltd. (NTR) has a median price target of $63.00. The highest price target is $70.00 and the lowest is $53.00.
According to current analyst ratings, NTR has 16 Buy ratings, 8 Hold ratings, and 2 Sell ratings. The stock is currently trading at $58.89. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict NTR stock could reach $63.00 in the next 12 months. This represents a 7.0% increase from the current price of $58.89. Please note that this is a projection by Wall Street analysts and not a guarantee.
The company generates revenue by producing and selling essential fertilizers like potash and nitrogen, alongside offering agricultural solutions and technology-driven services through its Retail segment. Nutrien operates a vast distribution network with over 1,500 retail locations, allowing it to effectively reach farmers and agricultural businesses globally.
The highest price target for NTR is $70.00 from Andrew Wong at RBC Capital, which represents a 18.9% increase from the current price of $58.89.
The lowest price target for NTR is $53.00 from Duffy Fischer at Goldman Sachs, which represents a -10.0% decrease from the current price of $58.89.
The overall analyst consensus for NTR is bullish. Out of 35 Wall Street analysts, 16 rate it as Buy, 8 as Hold, and 2 as Sell, with a median price target of $63.00.
Stock price projections, including those for Nutrien Ltd., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.